Journal
SUPPORTIVE CARE IN CANCER
Volume 21, Issue 5, Pages 1487-1495Publisher
SPRINGER
DOI: 10.1007/s00520-013-1758-y
Keywords
Febrile neutropenia; MASCC score; Low-risk identification
Ask authors/readers for more resources
The Multinational Association for Supportive Care in Cancer risk index score developed, through a multinational collaboration, was published in 2000 with the aim to identify patients with chemotherapy-induced febrile neutropenia at low risk of serious medical complication development. It has been endorsed as a reliable tool since 2002 by Infectious Diseases Society of America. Ten years after, we thought worth to review its use, its characteristics in the external validations that occurred after the initial publication and also to review how the recognition of a group of patients at low risk has changed the management of febrile neutropenia. We also raise the issue of identification of high-risk patients that remains a challenge today.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available